TY - JOUR AU - Choi, J. Isabelle PY - 2018 TI - Medically inoperable stage I non-small cell lung cancer: best practices and long-term outcomes JF - Translational Lung Cancer Research; Vol 8, No 1 (February 01, 2019): Translational Lung Cancer Research (Stereotactic Body Radiation Therapy for Thoracic Malignancies) Y2 - 2018 KW - N2 - Early-stage non-small cell lung cancer (ES-NSCLC) currently represents a minority of all NSCLC diagnoses but, with ongoing refinement and improvement of treatment approaches, is a group with increasing likelihood of long-term disease control and survival. A significant proportion of this population will not be optimal candidates for definitive surgical resection due to tumor characteristics, patient frailty, or comorbid status. The clinical evidence to support the use of stereotactic body radiation therapy (SBRT) in patients with medically inoperable stage I NSCLC is growing as long-term data are obtained. In this review, initial workup, SBRT delivery considerations, recent trial data, and post-treatment surveillance of this population are discussed. UR - https://tlcr.amegroups.org/article/view/22799